Europe Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Country and Growth Forecast, 2023 - 2030

• Bristol Myers Squibb Company
• Merck & Co. Inc.
• AstraZeneca PLC
• Novartis AG
• Eli Lilly And Company
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Johnson & Johnson
• Amgen Inc.
• Sanofi S.A.